Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGD | P52209 | 3/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | PEPD | P12955 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9738739 | 1.00 | PGD (0.33) | PGDCA4PEPD | |
| SCHEMBL9738103 | 1.00 | PGD (0.33) | PGDCA4PEPD | |
| SCHEMBL9737448 | 1.00 | PGD (0.33) | PGDCA4PEPD | |
| SCHEMBL9738277 | 1.00 | PGD (0.33) | PGDCA4PEPD | |
| SCHEMBL9736029 | 1.00 | PGD (0.33) | PGDCA4PEPD | |
| SCHEMBL9738106 | 1.00 | PGD (0.33) | PGDCA4PEPD | |
| SCHEMBL9738142 | 0.98 | PGD (0.32) | PGDCA4 | |
| SCHEMBL17671289 | 0.98 | PGD (0.32) | PGDCA4 | |
| SCHEMBL9737343 | 0.98 | PGD (0.32) | PGDCA4 | |
| SCHEMBL6544113 | 0.98 | PGD (0.32) | PGDCA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| WO-2026102434-A1 | USES OF PURINE NUCLEOSIDASE AND AMP PHOSPHORYLASE | CODEXIS, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| WO-2025019764-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | MATTERWORKS INC (US) | 2025-01-23 | — | — | WO | claimed |
| US-20230137741-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | MATTERWORKS INC | 2023-05-04 | — | — | US | claimed |
| WO-2023077166-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | MATTERWORKS INC (US) | 2023-05-04 | — | — | WO | claimed |
| CN-112852859-A | Method for improving synthesis capacity of filamentous fungi organic acid | 中国科学院天津工业生物技术研究所 | 2021-05-28 | — | — | CN | claimed |
| EP-2090304-A2 | Use of sugar phosphates, sugar phosphate analogues, amino acids and/or amino acid analogues for modulating the glycose-enzyme complex, the malate aspartate shuttle and/or transaminases | ScheBo Biotech AG (DE) | 2009-08-19 | — | — | EP | claimed |
| US-20050054584-A1 | Use of sugar phosphates, sugar phosphate analog, amino acids, amino acid analogs for modulating transaminases and/or the association of p36/ malate dehydrogenase | SCHEBO(R).BIOTECH AG (DE) | 2005-03-10 | — | — | US | claimed |
| US-20040235755-A1 | Use of amino acids amino acid alogues, sugar phosphates and sugar phosphate analogues for treatment of tumors, treatment of sepsis and immunosuppression | SCHEBO, BIOTECH AG (DE) | 2004-11-25 | — | — | US | claimed |
| EP-1372646-A2 | USE OF SUGAR PHOSPHATES, SUGAR PHOSPHATE ANALOGUES, AMINO ACIDS, AMINO ACID ANALOGES FOR MODULATING TRANSAMINASES AND/OR THE ASSOCIATION OF P36/MALATE DEHYDROGENASE | Schebo Biotech AG (DE) | 2004-01-02 | — | — | EP | claimed |
| WO-2002072078-A9 | USE OF SUGAR PHOSPHATES, AMINO ACIDS, AMINO ACID ANALOGS, E.G. CARBOMETHOXYPROPIONYL CYANIDE FOR REDUCING WEIGHT OR DIABETES COMPLICATIONS | EIGENBRODT ERICH (DE) | 2003-01-30 | — | — | WO | claimed |
| WO-2002072078-A2 | USE OF SUGAR PHOSPHATES, AMINO ACIDS, AMINO ACID ANALOGS, E.G. CARBOMETHOXYPROPIONYL CYANIDE FOR REDUCING WEIGHT OR DIABETES COMPLICATIONS | EIGENBRODT ERICH (DE) | 2002-09-19 | — | — | WO | claimed |
| EP-0147867-A2 | Method for the enzymatic determination of inorganic phosphate, and its application | de Groot, Herbert, Dr. (DE) | 1985-07-10 | — | — | EP | claimed |
| US-20260148950-A1 | METHODS AND SYSTEMS FOR PREDICTIVE ANALYSIS BY MASS SPECTROMETRY | MATTERWORKS INC (US) | 2026-05-28 | — | — | US | disclosed |
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | disclosed |
| WO-2026102434-A1 | USES OF PURINE NUCLEOSIDASE AND AMP PHOSPHORYLASE | CODEXIS, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| US-20030157575-A1 | Chemical proteomics | PROTANA INC. (CA) | 2003-08-21 | — | — | US | disclosed |
| WO-2003064704-A1 | CHEMICAL PROTEOMICS | MDS PROTEOMICS, INC. (CA) | 2003-08-07 | — | — | WO | disclosed |
| WO-2002072078-A9 | USE OF SUGAR PHOSPHATES, AMINO ACIDS, AMINO ACID ANALOGS, E.G. CARBOMETHOXYPROPIONYL CYANIDE FOR REDUCING WEIGHT OR DIABETES COMPLICATIONS | EIGENBRODT ERICH (DE) | 2003-01-30 | — | — | WO | disclosed |
| WO-2002072077-A2 | USE OF AMINO ACIDS, AMINO ACID ANALOGUES, SUGAR PHOSPHATES AND SUGAR PHOSPHATE ANALOGUES FOR TREATMENT OF TUMORS, TREATMENT OF SEPSIS AND IMMUNOSUPPRESSION | SCHEBO BIOTECH AG (DE) | 2002-09-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235755-A1 | Use of amino acids amino acid alogues, sugar phosphates and sugar phosphate analogues for treatment of tumors, treatment of sepsis and immunosuppression | PDK4, PDK1, PDK2 | PGD 23/4885CA4 1029/4885PEPD 610/4885 |
| US-20260148950-A1 | METHODS AND SYSTEMS FOR PREDICTIVE ANALYSIS BY MASS SPECTROMETRY | SRMS, PTMS, CALCB | PGD 631/4885CA4 1008/4885PEPD 130/4885 |
| US-20050054584-A1 | Use of sugar phosphates, sugar phosphate analog, amino acids, amino acid analogs for modulating transaminases and/or the association of p36/ malate dehydrogenase | MPHOSPH6, G6PD, GOT1 | PGD 106/4885CA4 1403/4885PEPD 78/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.